The U.S. Food and Drug Administration authorized emergency use of the bivalent Moderna COVID-19 Vaccine in people 6 months and older, the bivalent Pfizer-BioNTech COVID-19 Vaccine in people 6 months and older, and the primary series Novavax COVID-19 Vaccine in people 12 and older. This means each vaccine was proven safe and effective for its respective age group.
As with all vaccines, there will be ongoing safety monitoring for all COVID-19 vaccines. Novavax boosters and Johnson & Johnson primary and booster vaccinations are authorized in limited situations when other vaccines are not available.